REV1 and breast cancer: However, as shown in Figures 8E–H, survival curves identified that high expression of REV1 indicated better prognosis in lung [OS 1: HR, 0.54, 95% CI, 0.37–0.79, p = 0.001760; OS 2: HR, 0.37, 95% CI, 0.20–0.70, p = 0.002163; relapse free survival (RFS): HR, 0.09, 95% CI, 0.03–0.28, p = 0.000033] and breast cancer (DSS: HR, 0.56, 95% CI, 0.38–0.81, p = 0.002398).